Guidance and Reports
Health Protection Guidance and Reports
| Title | Disease | Category | Date | File Size | Download |
|---|---|---|---|---|---|
| Evidence to decision: HIV PEP - Occupational exposure recommendations | Emi | Information | 05 Mar 2024 | 245.40 KB | Download |
| Evidence to decision: HIV PEP - Sexual exposure recommendations | Emi | Information | 05 Mar 2024 | 246.32 KB | Download |
| Evidence to decision: HIV PEP - Needlestick exposure from a discarded needle in the community and Shared injecting paraphernalia recommendations | Emi | Information | 05 Mar 2024 | 217.67 KB | Download |
| Table 11 - HIV PEP drugs, doses and side effects | Emi | Information | 04 Mar 2024 | 145.80 KB | Download |
| Table 10 - Suggested Paediatric PEP Regimens | Emi | Information | 04 Mar 2024 | 37.21 KB | Download |
| Table 9 - Estimated risk of HIV transmission by type of exposure where source HIV status is unknown | Emi | Information | 04 Mar 2024 | 123.04 KB | Download |
| Table 9 - Estimated risk of HIV transmission by type of exposure where source HIV status is unknown | Emi | Information | 04 Mar 2024 | 123.04 KB | Download |
| Table 8 - Risk of HIV transmission per exposure where source is known to be living with HIV and not on ART | Emi | Information | 04 Mar 2024 | 68.26 KB | Download |
| Table 7 - Impact of suppressive antiretroviral therapy on risk of HIV acquisition | Emi | Information | 04 Mar 2024 | 92.17 KB | Download |
| Table 6 - HIV PEP recommendations by type of exposure and source status | Emi | Information | 04 Mar 2024 | 176.99 KB | Download |